Hongzhi Wang

Title: Innovations in Liver Cancer Treatment by Hongzhi Wang

Introduction

Hongzhi Wang is an accomplished inventor based in Columbus, OH. He has made significant contributions to the field of cancer treatment, particularly focusing on liver cancer. His innovative approach involves the use of RNA nanoparticles to enhance drug delivery and efficacy.

Latest Patents

Hongzhi Wang holds a patent for an RNA nanoparticle designed for liver cancer treatment. The patent, which is a groundbreaking development, discloses compositions and methods for targeted treatment of liver cancers using Paclitaxel and miR-122. The composition comprises an RNA nanostructure conjugated to a hepatocyte targeting ligand, paclitaxel, and miR-122 for effective intracellular drug delivery to liver cancer cells. The RNA nanoparticle is constructed from three or more self-assembled synthetic RNA oligonucleotides that form a central core domain, with at least three double-stranded arms extending away from the core.

Career Highlights

Hongzhi Wang is affiliated with The Ohio State University, where he continues to advance research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from liver cancer.

Collaborations

Hongzhi Wang has collaborated with notable colleagues in his field, including Peixuan Guo and Satheesh Ellipilli. Their combined expertise contributes to the innovative research and development of effective cancer treatments.

Conclusion

Hongzhi Wang's contributions to liver cancer treatment through his patented RNA nanoparticle technology represent a significant advancement in medical science. His work exemplifies the potential of innovative approaches to improve patient care and treatment efficacy.